143 related articles for article (PubMed ID: 19492210)
1. It is time to remove propoxyphene from clinical practice.
Lipman AG
J Pain Palliat Care Pharmacother; 2009; 23(2):104-5. PubMed ID: 19492210
[No Abstract] [Full Text] [Related]
2. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity.
Barkin RL; Barkin SJ; Barkin DS
Am J Ther; 2006; 13(6):534-42. PubMed ID: 17122535
[TBL] [Abstract][Full Text] [Related]
3. Why pick on propoxyphene? The evidence demands it.
Hutchison LC
J Ark Med Soc; 2010 Aug; 107(2):36-7. PubMed ID: 20806582
[TBL] [Abstract][Full Text] [Related]
4. Food and Drug Administration recommends against the continued use of propoxyphene.
Food And Drug Administration Public Health Service U S Department Of Health And Human Services
J Pain Palliat Care Pharmacother; 2011; 25(1):80-2. PubMed ID: 21426228
[TBL] [Abstract][Full Text] [Related]
5. Close vote by FDA advisers favors propoxyphene withdrawal.
Traynor K
Am J Health Syst Pharm; 2009 Mar; 66(6):518-20. PubMed ID: 19265176
[No Abstract] [Full Text] [Related]
6. Problems with propoxyphene.
Perin ML
Am J Nurs; 2000 Jun; 100(6):22. PubMed ID: 10892320
[No Abstract] [Full Text] [Related]
7. Propoxyphene-induced torsades de pointes.
Adler A; Viskin S; Bhuiyan ZA; Eisenberg E; Rosso R
Heart Rhythm; 2011 Dec; 8(12):1952-4. PubMed ID: 21763256
[No Abstract] [Full Text] [Related]
8. Dextropropoxyphene: withdrawal from the US market requested: harmful drug.
Prescrire Int; 2009 Aug; 18(102):166-7. PubMed ID: 19746529
[No Abstract] [Full Text] [Related]
9. Consumer group urges Food and Drug Administration to ban drug Darvon.
Willens JS
Pain Manag Nurs; 2006 Jun; 7(2):43. PubMed ID: 16730316
[No Abstract] [Full Text] [Related]
10. Substitutions for propoxyphene; Macrobid versus Macrodantin.
DeDea L
JAAPA; 2011 Feb; 24(2):16. PubMed ID: 21387964
[No Abstract] [Full Text] [Related]
11. Dextropropoxyphene combinations: Swedish market withdrawal.
Prescrire Int; 2006 Feb; 15(81):20. PubMed ID: 16548113
[No Abstract] [Full Text] [Related]
12. Profound metoprolol-induced bradycardia precipitated by acetaminophen-propoxyphene.
Marraffa JM; Lang L; Ong G; Lehmann DF
Clin Pharmacol Ther; 2006 Mar; 79(3):282-6. PubMed ID: 16513452
[TBL] [Abstract][Full Text] [Related]
13. Dextropropoxyphene: welcome withdrawal from a French hospital's formulary.
Prescrire Int; 2008 Jun; 17(95):112. PubMed ID: 18629970
[TBL] [Abstract][Full Text] [Related]
14. FDA raises safety issues concerning propoxyphene.
Aschenbrenner DS
Am J Nurs; 2010 Jan; 110(1):59-60. PubMed ID: 20032671
[No Abstract] [Full Text] [Related]
15. The influence of propoxyphene withdrawal on opioid use in veterans.
Hayes CJ; Hudson TJ; Phillips MM; Bursac Z; Williams JS; Austin MA; Edlund MJ; Martin BC
Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1180-8. PubMed ID: 26248742
[TBL] [Abstract][Full Text] [Related]
16. Dextropropoxyphene: withdrawn in the EU. Withdrawn from pharmacies in France.
Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19746528
[No Abstract] [Full Text] [Related]
17. Recurrent hypoglycemia in a hemodialysis patient related to propoxyphene treatment.
Lee HT; Tseng WC; Tarng DC
J Chin Med Assoc; 2007 Jul; 70(7):286-8. PubMed ID: 17631465
[TBL] [Abstract][Full Text] [Related]
18. Overdose risk prompts UK withdrawal of propoxyphene combination.
Committee on the Safety of Medicines of the UK
J Pain Palliat Care Pharmacother; 2006; 20(4):49-50. PubMed ID: 17182507
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal of propoxyphene from the US market: implications for the clinical nurse specialist.
O'Malley P
Clin Nurse Spec; 2011; 25(2):55-6. PubMed ID: 21311244
[No Abstract] [Full Text] [Related]
20. In brief: propoxyphene toxicity.
Med Lett Drugs Ther; 2010 Sep; 52(1346):69. PubMed ID: 20814401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
